4.6 Article

CD4(+) T Cell Count Progress and Influencing Factors of Recovery in AIDS Patients with Virological Failure in Sichuan Province: A Retrospective Cohort Study

期刊

INFECTION AND DRUG RESISTANCE
卷 15, 期 -, 页码 6985-6999

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/IDR.S378799

关键词

HIV; AIDS; antiretroviral therapy; CD4(+) T cells count

资金

  1. Science and Technology Project of Sichuan Provincial Health Committee
  2. Sichuan Science and Technology program
  3. 2022 scientific research project of Sichuan Center for Disease Control and Prevention
  4. [20PJ121]
  5. [2020YJ0449]
  6. [2022NSFSC1547]
  7. [zx202201]
  8. [zx202112]

向作者/读者索取更多资源

This study analyzed the CD4(+) T cell count changes of PLWH infected with different HIV-1 subtypes in Sichuan Province after treatment, identifying factors such as virus subtype, gender, age, and education level that influence CD4(+) T cell count growth.
Background: Choosing patients with HIV/AIDS (PLWH) with virologic failure observed in the course of treatment, and analyzing the CD4(+) T cell count of PLWH with different subtypes of virus and the risk factors of CD4 (+) T cell count recoveryMethods: Analyze and evaluate the change of median CD4(+) T cell count of PLWH infected with different HIV-1 subtypes in Sichuan Province after treatment by rank sum test. Univariate and multivariate logistic regression models were used to analyze the risk factors on CD4(+) T cell count growth after PLWH treatment.Results: A total of 4977 cases were analysed, including CRF07_BC 2358 cases (47.38%), CRF01_AE 1507 cases (30.28%), CRF08_BC 577 cases (11.59%), CRF85_BC 303 cases (6.09%) and other subtypes 232 cases (4.66%). PLWH infected with CRF85_BC had lower median CD4(+) T cell count after treatment (p < 0.05). It was found that protective factors to increase CD4 (+) T cell count (p < 0.05) including females, Yi people, married or cohabiting, educational level at primary school or above, initial and recent treatment with Tenofovir + Lamivudine + Nevirapine Wellen, the second-line regimen with lopinavir/ritonavir (LPV/r) and the treatment time is more than 24 months. However, over 50 years old, the disease course is in AIDS stage, the infection of CRF01_AE and CRF85_BC virus was the risk factor on CD4(+) T cell count increase (p < 0.05). PLWH with higher initial CD4 level had a lower ratio of CD4(+) T cell count increase (>= 50 cells/mu L) (p < 0.05).Conclusion: Age, sex, ethnicity, marriage, education, disease status, treatment protocols, treatment time, initial CD4(+) T cell count, and virus subtype are the influencing factors of PLWH CD4(+) T cell count increase. The poor recovery of CD4(+) T cell count after treatment was observed in PLWH infected with CRF85_BC virus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据